|
|
Volumn 2, Issue 1, 2002, Pages 1-4
|
|
Pharmacogenomics: A critical component of patient stratification during drug development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
CLINICAL RESEARCH;
DISEASE PREDISPOSITION;
DRUG DEVELOPMENT;
DRUG LABELING;
DRUG MARKETING;
EDITORIAL;
GENE MUTATION;
GENETIC MARKER;
PATIENT SELECTION;
PHARMACOGENOMICS;
PHENOTYPE;
CLINICAL TRIAL;
DRUG SCREENING;
GENOME;
HUMAN;
PHARMACOGENETICS;
CLINICAL TRIALS;
DRUG EVALUATION;
GENETIC MARKERS;
GENOME, HUMAN;
HUMAN;
PHARMACOGENETICS;
HUMANS;
|
|
EID: 0035998302
PISSN: 14737140
EISSN: None
Source Type: Journal
DOI: 10.1586/14787210.2.1.1 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
